With its NAOS platform, Synergia Medical is pioneering optoelectronics for neurostimulation medical devices.
NAOS is a powerful and versatile technological platform that encompasses various breakthrough innovations. Unique quartz encapsulation, light emitter and receiver, wireless charging, custom optical lead, photovoltaic cells and enhanced electrode.
Its lead product is a next-generation, small-form, MRI-safe, implanted neurostimulation device for drug-resistant epilepsy, with a range of further therapeutic applications.
We are in the Accenture Innovation Awards 2018 Top 25
For the last couple of months the Accenture Innovation Awards (AIA) has brought us on a journey. Hereby we are proud to announce that NAOS has made it to the Top 25 Health innovators in the AIA competition!
Synergia raises €8.1 million in Series A
Novel opto-electronic neurostimulation device in final testing prior to CE mark submission
Board strengthened with appointments of Reinhard Krickl as Chairman, and Guy Heynen MD and Pierre Detrixhe
Jacques van Rijckevorsel rewarded for his contribution and named Director Emeritus
Synergia Medical welcomes Reinhard Krickl
Reinhard joined the Board of Synergia Medical as non-executive director with a great experience in international neurostimulation industry.